Liu RR - Search Results

1

[The prognosis and related factors impacting renal response in newly diagnosed multiple myeloma patients with renal impairment].

Shi M, Liu RR, Jin YY, Shi QL, Shen XX, Zhang R, Chen LJ. Shi M, et al. Among authors: liu rr. Zhonghua Yi Xue Za Zhi. 2024 Oct 8;104(37):3528-3534. doi: 10.3760/cma.j.cn112137-20240119-00138. Zhonghua Yi Xue Za Zhi. 2024. PMID: 39375135 Chinese.

2

N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21^cip1/waf1/CDK2-Cyclin E1 axis-mediated cell cycle transition.

Liu R, Miao J, Jia Y, Kong G, Hong F, Li F, Zhai M, Zhang R, Liu J, Xu X, Wang T, Liu H, Hu J, Yang Y, He A. Liu R, et al. Oncogene. 2023 May;42(20):1607-1619. doi: 10.1038/s41388-023-02675-w. Epub 2023 Apr 3. Oncogene. 2023. PMID: 37012388 Free PMC article.

3

[Alteration and significance of serum lipid levels and nutritional status during BCMA-CAR-T-cell therapy in patients with refractory or relapsed multiple myeloma: a retrospective study based on LEGEND-2].

Xu XZ, Liu R, Zhao WH, Yang Y, Liu J, Zhang WG, Bai J, He AL. Xu XZ, et al. Zhonghua Xue Ye Xue Za Zhi. 2023 Oct 14;44(10):838-844. doi: 10.3760/cma.j.issn.0253-2727.2023.10.008. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 38049336 Free PMC article. Chinese.

4

BATF promotes extramedullary infiltration through TGF-β1/Smad/MMPs axis in acute myeloid leukemia.

Zhang R, Miao J, Zhai M, Liu R, Li F, Xu X, Huang L, Wang T, Yang R, Yang R, Wang Y, He A, Wang J. Zhang R, et al. Mol Carcinog. 2024 Jun;63(6):1146-1159. doi: 10.1002/mc.23715. Epub 2024 Mar 13. Mol Carcinog. 2024. PMID: 38477642

5

Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia.

Li F, Miao J, Liu R, Zhang R, He A. Li F, et al. J Cancer Res Clin Oncol. 2024 Mar 20;150(3):144. doi: 10.1007/s00432-024-05676-8. J Cancer Res Clin Oncol. 2024. PMID: 38507057 Free PMC article.

6

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial.

Xu J, Wang BY, Yu SH, Chen SJ, Yang SS, Liu R, Chen LJ, Hou J, Chen Z, Zhao WH, He AL, Mi JQ, Chen SJ. Xu J, et al. J Hematol Oncol. 2024 Apr 24;17(1):23. doi: 10.1186/s13045-024-01530-z. J Hematol Oncol. 2024. PMID: 38659046 Free PMC article. Clinical Trial.

7

KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.

Zhai M, Miao J, Zhang R, Liu R, Li F, Shen Y, Wang T, Xu X, Gao G, Hu J, He A, Bai J. Zhai M, et al. J Cancer Res Clin Oncol. 2024 May 7;150(5):239. doi: 10.1007/s00432-024-05747-w. J Cancer Res Clin Oncol. 2024. PMID: 38713252 Free PMC article.

8

Importance of circulating adipocytokines in multiple myeloma: a systematic review and meta-analysis based on case-control studies.

Liu R, Gao D, Lv Y, Zhai M, He A. Liu R, et al. BMC Endocr Disord. 2022 Jan 25;22(1):29. doi: 10.1186/s12902-022-00939-2. BMC Endocr Disord. 2022. PMID: 35073877 Free PMC article.

9

A comprehensive analysis of coagulopathy during anti-B cell maturation antigen chimeric antigen receptor-T therapy in multiple myeloma, a retrospective study based on LEGEND-2.

Liu R, Lv Y, Hong F, Zhao W, Lei B, Liu J, Zhang W, He A, Wang F. Liu R, et al. Hematol Oncol. 2023 Oct;41(4):704-717. doi: 10.1002/hon.3155. Epub 2023 Apr 25. Hematol Oncol. 2023. PMID: 37186314

10

Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma.

Jia Y, Liu R, Shi L, Feng Y, Zhang L, Guo N, He A, Kong G. Jia Y, et al. BMC Cancer. 2023 Sep 12;23(1):859. doi: 10.1186/s12885-023-11371-7. BMC Cancer. 2023. PMID: 37700273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters